It has been suggested that such high expression of SKI blocks TGF-β transcriptional responses, in particular the induction of p21/WAF, resulting in an inactive TGF-β pathway in melanoma cells and lack of growth inhibitory activity of TGF-β [39,40]. The gene discussed is CDKN1A; the disease is melanoma.